Jamie Lee
Nurse Practitioner · Whitney, TXNPI 1356973192
Payments from drug & device makers
Across 385 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$900
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$521
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$469
- AstraZeneca$380
- Lilly USA, LLC$358
- GSK$357
- plus $3K from 31 others
What the payments were for
- Food & beverage$6,267100%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $900 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 41 | $521 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $469 |
| AstraZeneca | 21 | $380 |
| Lilly USA, LLC | 21 | $358 |
| GSK | 21 | $357 |
| Lundbeck LLC | 15 | $357 |
| Otsuka America Pharmaceutical, Inc. | 16 | $324 |
| Amgen | 18 | $302 |
| Novo Nordisk | 17 | $285 |
| Teva Pharmaceuticals USA, Inc. | 18 | $232 |
| Pfizer | 11 | $185 |
| Bayer | 9 | $172 |
| Merck | 9 | $163 |
| Kowa Pharmaceuticals America, Inc. | 9 | $158 |
| Idorsia Pharmaceuticals US Inc | 6 | $109 |
| Exact Sciences | 6 | $103 |
| Sanofi-aventis U.S. LLC | 6 | $93 |
| Dexcom, Inc. | 5 | $88 |
| E.r. Squibb & Sons, L.L.C. | 5 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $81 |
| Astellas Pharma US Inc | 5 | $79 |
| Biogen | 4 | $68 |
| Corium, LLC | 2 | $52 |
| Boehringer Ingelheim | 2 | $47 |
| Amarin Pharma, Inc. | 2 | $41 |
| Sanofi | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Paratek Pharmaceuticals, Inc. | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Novartis | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Halozyme Inc | 1 | $19 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Advanced Oxygen Therapy Inc. | 1 | $13 |
How this compares
$6,271 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 48 | $55,799 |
| OzempicSemaglutide | 38 | $40,448 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $30,908 |
| EliquisApixaban | 36 | $24,607 |
| JardianceEmpagliflozin | 22 | $20,418 |
| CreonLipase/Protease/Amylase | 16 | $15,286 |
| MyrbetriqMirabegron | 18 | $9,460 |
| FarxigaDapagliflozin Propanediol | 12 | $8,883 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $7,974 |
| XareltoRivaroxaban | 11 | $5,577 |
| Gabapentin | 242 | $3,032 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 121 | $2,823 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $1,812 |
| Tramadol Hcl | 136 | $1,615 |
| Omeprazole | 100 | $1,603 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $358 | $55,79948 claims |
| Novo NordiskOzempic | $285 | $40,44838 claims |
| GSKTrelegy Ellipta | $357 | $30,90841 claims |
| PfizerEliquis | $185 | $24,60736 claims |
| Boehringer IngelheimJardiance | $47 | $20,41822 claims |
| AbbVieCreon | $900 | $15,28616 claims |
| Astellas Pharma US IncMyrbetriq | $79 | $9,46018 claims |
| AstraZenecaFarxiga | $380 | $8,88312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Whitney
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
- Monica WhiteLongview$118K
- Onna FeuchterSouthlake$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.